Abstract
Although emerging evidence suggests that vitamin E may contribute to blood pressure improvement, the effects of vitamin E on systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) are still controversial. The aim was to evaluate the influence of vitamin E on SBP, DBP, and MAP through meta-analysis. We identified all studies that assessed the effect of vitamin E supplementation on SBP, DBP, and MAP from PubMed/Medline, SCOPUS, and Google scholar up to March 2018. Weighted mean differences (WMD) and 95% confidence interval (CI) were expressed as effect size. Pre-specified subgroup analysis was conducted to evaluate potential sources of heterogeneity. Meta-regression analyses were performed to investigate association between blood pressure-lowering effects of vitamin E and duration of follow-up and dose of treatment. Eighteen trials, comprising 839 participants met the eligibility criteria. Results of this study showed that compared to placebo, SBP decreased significantly in vitamin E group (WMD = −3.4 mmHg, 95% CI = −6.7 to −0.11, P < 0.001), with a high heterogeneity across the studies (I2 = 94.0%, P < 0.001). Overall, there were no significant effects on DBP and MAP. This meta-analysis suggested that vitamin E supplements decreased only SBP and had no favorable effect on DBP and MAP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet (Lond, Engl). 2005;365:217–23.
Campbell NR, Lackland DT, Niebylski ML. High blood pressure: why prevention and control are urgent and important: a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens (Greenwich, Conn). 2014;16:551–3.
Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000;18:521–9.
Abed Y, Abu-Haddaf S. Risk factors of hypertension at UNRWA primary health care centers in Gaza Governorates. ISRN Epidemiology. 2013;2013:9.
Puzserova A, Bernatova I. Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms. Physiol Res. 2016;65:S309–S342.
Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233–46.
Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–42.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New Engl J Med. 2000;342:145–53.
Kizhakekuttu TJ, Widlansky ME. Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther. 2010;28:e20–e32.
Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. 2001;10:247–55.
Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–4.
Leonard SW, Traber MG. Methods for assessment of Vitamin E. In: Laboratory: Assessment of Vitamin Status. 1st edn: Elsevier; 2019. P. 79–105.
Sen CK, Rink C, Khanna S. Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J Am Coll Nutr. 2010;29:314s–23s.
Sen CK, Rink C, Khanna S. Palm oil–derived natural vitamin E α-tocotrienol in brain health and disease. J Am Coll Nutr. 2010;29:314S–23S.
Boshtam M, Rafiei M, Sadeghi K, Sarraf-Zadegan N. Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res. 2002;72:309–14.
Mottram P, Shige H, Nestel P. Vitamin E improves arterial compliance in middle-aged men and women. Atherosclerosis. 1999;145:399–404.
Aryaeian N, Shahram F, Djalali M, Eshragian MR, Djazayeri A, Sarrafnejad A. et al. Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis. Vasc Health Risk Manag. 2008;4:1423–32.
Rafraf M, Bazyun B, Sarabchian MA, Safaeiyan A, Ghaemmaghami Hezaveh SJ. Impact of vitamin E supplementation on blood pressure and Hs-CRP in type 2 diabetic patients. Health Promot Perspect. 2012;2:72–9.
Mahdy ZA, Siraj HH, Khaza’ai H, Mutalib MS, Azwar MH, Wahab MA. et al. Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?. Acta Medica (Hradec Kralove)2013;56:104–9.
Gazis A, White DJ, Page SR, Cockcroft JR. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med. 1999;16:304–11.
Nang C, Piano B, Lewis A, Lycett K, Woodhouse M. Using the PICOS model to design and conduct a systematic search: a speech pathology case study. Presented at Research Week 2015. Edith Cowan University, Perth, Western Australia.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014;28:633–42.
Ekhlasi G, Zarrati M, Agah S, Hosseini AF, Hosseini S, Shidfar S. et al. Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. EXCLI J. 2017;16:278–90.
Hejazi N, Dabbaghmanesh MH, Mazloom Z, Dashtabi A. Effects of vitamin E on fasting and postprandial oxidative stress, inflammatory markers, glucose status, insulin resistance, blood pressure and pulse rate in type-2 diabetic patients: a randomized clinical trial. Galen Med J. 2015;4:67–74.
Shidfar F, Rezai KH, Hosseini SH, Haydari I. The effects of vitamin E on insulin resistance and cardiovascular diseases risk factors in metabolic syndrome. IJEM. 2009;10:445–54.
Economides PA, Khaodhiar L, Caselli A, Caballero AE, Keenan H, Bursell SE. et al. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes. 2005;54:204–11.
Jessup JV, Horne C, Yarandi H, Quindry J. The effects of endurance exercise and vitamin E on oxidative stress in the elderly. Biol Res Nurs. 2003;5:47–55.
Stonehouse W, Brinkworth GD, Thompson CH, Abeywardena MY. Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: a randomised controlled trial. Atherosclerosis. 2016;254:205–14.
Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD. et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens. 2007;25:227–34.
Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of vitamin e and glutathione on glucose metabolism: role of magnesium. Hypertension. 1999;34:1002–6.
Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M. et al. Effects of Vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens. 2000;13:564–7.
Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis. 2005;182:367–74.
Patil SM, Chaudhuri D, Dhanakshirur GB. Role of alpha-tocopherol in cardiopulmonary fitness in endurance athletes, cyclists. Indian J Physiol Pharmacol. 2009;53:375–9.
Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998;32:1672–9.
Rasool AH, Yuen KH, Yusoff K, Wong AR, Rahman AR. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol (Tokyo). 2006;52:473–8.
IMcSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP. et al. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med. 2005;22:703–10.
Raghuvanshi R, Chandra M, Mishra A, Misra MK. Effect of vitamin E administration on blood pressure following reperfusion of patients with myocardial infarction. Exp Clin Cardiol. 2007;12:87–90.
González J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: new insights. World J Cardiol. 2014;6:353.
Ndisang JF, Vannacci A, Rastogi S. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxid Med Cell Longev. 2014;https://www.hindawi.com/journals/omcl/2014/506948/.
Musiek ES, Yin H, Milne GL, Morrow JD. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids. 2005;40:987–94.
Chen S-P, Chung Y-T, Liu T-Y, Wang Y-F, Fuh J-L, Wang S-J. Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radic Biol Med. 2013;61:243–8.
Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin LJ, et al. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic Biol Med. 2007;42:1730–5.
Wu D, Liu L, Meydani M, Meydani SN. Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J Nutr. 2005;135:1847–53.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Emami, M.R., Safabakhsh, M., Alizadeh, S. et al. Effect of vitamin E supplementation on blood pressure: a systematic review and meta-analysis. J Hum Hypertens 33, 499–507 (2019). https://doi.org/10.1038/s41371-019-0192-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-019-0192-0
This article is cited by
-
A systematic review with meta-analysis of the relation of aflatoxin B1 to growth impairment in infants/children
BMC Pediatrics (2023)
-
Dietary vitamin E intake and new-onset hypertension
Hypertension Research (2023)
-
Fruit and vegetable consumption and the risk of hypertension: a systematic review and meta-analysis of prospective studies
European Journal of Nutrition (2023)
-
Diet quality in relation to the risk of hypertension among Iranian adults: cross-sectional analysis of Fasa PERSIAN cohort study
Nutrition Journal (2021)
-
Nutritional and medical food therapies for diabetic retinopathy
Eye and Vision (2020)